• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型预后性浸润性病变指数在乳腺原位导管癌伴微小浸润中的应用。

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast.

作者信息

He Xiaofang, Ye Feng, Li Mei, Yu Ping, Xiao Xiangsheng, Tang Hailin, Xie Xiaoming

机构信息

Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.

Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

出版信息

Cancer Med. 2017 Nov;6(11):2489-2496. doi: 10.1002/cam4.1175. Epub 2017 Oct 4.

DOI:10.1002/cam4.1175
PMID:28980458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5673919/
Abstract

Multiple invasive foci has been shown to increase the risk of lymph node metastasis (LNM) in early breast cancer, but its prognostic implication remains unknown. We aimed to identify the prognostic value of the number of invasive foci in ductal carcinoma in situ with minimal invasion of the breast (DCIS-MI), and further establish a prognostic invasive lesion index (ILI). A total of 193 patients with DCIS-MI (the invasive component was up to 10 mm in diameter) were included. Univariate and multivariate analysis (logistic regression) were used to evaluate the predictive value of the number of invasive foci in LNM. The Kaplan-Meier curve was used for survival analysis. More than five invasive foci was an independent predictor for LNM (OR, 2.67, 95% CI, 1.12-6.33, P = 0.026), and associated with significantly shorter disease-free survival (DFS) and overall survival (OS) compared with no more than five invasive foci (mean DFS 123.8 vs. 148.0 months, P = 0.002; and mean OS 133.5 vs. 151.4 months, P = 0.025). The ILI was established by the sum scores of the number of invasive foci and the invasive component size, having an optimal cut-off point of 5.5 scores. The high-ILI group (ILI >5 scores) had a higher incidence of LNM (23.6% vs. 6.9%) and worse prognosis than the low-ILI group (ILI ≤5 scores). In conclusion, more than five invasive foci was an independent predictor for LNM and an unfavorable prognostic parameter. The ILI could potentially be used to predict survival prognosis in patients with DCIS-MI.

摘要

多个浸润灶已被证明会增加早期乳腺癌发生淋巴结转移(LNM)的风险,但其预后意义仍不明确。我们旨在确定乳腺微浸润导管原位癌(DCIS-MI)中浸润灶数量的预后价值,并进一步建立一个预后浸润性病变指数(ILI)。共纳入193例DCIS-MI患者(浸润成分直径最大为10毫米)。采用单因素和多因素分析(逻辑回归)来评估浸润灶数量对LNM的预测价值。采用Kaplan-Meier曲线进行生存分析。超过5个浸润灶是LNM的独立预测因素(OR为2.67,95%CI为1.12 - 6.33,P = 0.026),与不超过5个浸润灶相比,其无病生存期(DFS)和总生存期(OS)显著缩短(平均DFS为123.8个月对148.0个月,P = 0.002;平均OS为133.5个月对151.4个月,P = 0.025)。ILI通过浸润灶数量和浸润成分大小的得分总和来确定,最佳截断点为5.5分。高ILI组(ILI>5分)的LNM发生率更高(23.6%对6.9%),且预后比低ILI组(ILI≤5分)更差。总之,超过5个浸润灶是LNM的独立预测因素和不良预后参数。ILI可能可用于预测DCIS-MI患者的生存预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524d/5673919/f9fbe6d265bf/CAM4-6-2489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524d/5673919/0945bb9ac5dd/CAM4-6-2489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524d/5673919/f9fbe6d265bf/CAM4-6-2489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524d/5673919/0945bb9ac5dd/CAM4-6-2489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524d/5673919/f9fbe6d265bf/CAM4-6-2489-g002.jpg

相似文献

1
Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast.一种新型预后性浸润性病变指数在乳腺原位导管癌伴微小浸润中的应用。
Cancer Med. 2017 Nov;6(11):2489-2496. doi: 10.1002/cam4.1175. Epub 2017 Oct 4.
2
Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.肿瘤厚度和组织学特征作为术前诊断的导管原位癌中浸润灶的预测指标。
Hum Pathol. 2017 Jun;64:145-155. doi: 10.1016/j.humpath.2017.04.004. Epub 2017 Apr 20.
3
Clinic-Pathological Features of Breast Ductal Carcinoma with Micro-Invasion.乳腺导管癌微小浸润的临床病理特征。
Cancer Invest. 2020 Feb;38(2):113-121. doi: 10.1080/07357907.2020.1715422. Epub 2020 Jan 24.
4
Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.不同亚型乳腺癌在乳腺导管原位癌(DCIS)、微浸润性 DCIS 和伴有浸润成分的 DCIS 中的分布情况。
Ann Surg Oncol. 2011 May;18(5):1342-8. doi: 10.1245/s10434-010-1407-3. Epub 2010 Nov 2.
5
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.Runx2表达作为浸润性导管癌潜在的预后标志物
Pathol Oncol Res. 2016 Jul;22(3):461-70. doi: 10.1007/s12253-015-0018-5. Epub 2015 Nov 23.
6
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
7
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.伴导管原位癌成分的浸润性导管癌(IDC/DCIS)与单纯浸润性导管癌(IDC)的比较:临床病理特征、分子亚型和临床结局的比较。
J Cancer Res Clin Oncol. 2019 Jul;145(7):1877-1886. doi: 10.1007/s00432-019-02930-2. Epub 2019 May 14.
8
Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.伴有微浸润的乳腺导管原位癌的生物学行为及长期预后
Oncotarget. 2016 Sep 27;7(39):64182-64190. doi: 10.18632/oncotarget.11639.
9
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
10
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.人表皮生长因子受体 2 阳性导管原位癌患者后续原位和浸润性乳腺癌的风险。
Ann Oncol. 2015 Apr;26(4):682-687. doi: 10.1093/annonc/mdv013. Epub 2015 Jan 18.

引用本文的文献

1
Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion.保乳手术联合放疗与乳房切除术治疗伴有微浸润的乳腺导管原位癌的生存结局比较。
Sci Rep. 2022 Nov 22;12(1):20132. doi: 10.1038/s41598-022-24630-7.

本文引用的文献

1
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.乳腺癌——美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14.
2
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.浸润性乳腺癌,2016年第1版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2016 Mar;14(3):324-54. doi: 10.6004/jnccn.2016.0037.
3
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
4
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
5
Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.多灶性和淋巴结转移对微浸润性乳腺癌的预后和治疗的影响。
Ann Surg Oncol. 2013 Aug;20(8):2576-81. doi: 10.1245/s10434-013-2924-7. Epub 2013 Mar 7.
6
The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential.1 - 14毫米浸润性乳腺癌中病灶的分布及其与转移潜能的关系。
Virchows Arch. 2009 Aug;455(2):109-15. doi: 10.1007/s00428-009-0808-9. Epub 2009 Jul 21.
7
The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent.多灶性乳腺癌的转移能力:广泛肿瘤与局限性肿瘤的比较。
Hum Pathol. 2009 Feb;40(2):199-205. doi: 10.1016/j.humpath.2008.07.001. Epub 2008 Sep 16.
8
Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.500例连续性乳腺癌病例在大幅组织学切片中病变分布的临床相关性。
Cancer. 2007 Dec 1;110(11):2551-60. doi: 10.1002/cncr.23052.
9
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.医生,我的前哨淋巴结呈阳性的几率有多大?一种经过验证的风险评估列线图。
J Clin Oncol. 2007 Aug 20;25(24):3670-9. doi: 10.1200/JCO.2006.08.8013. Epub 2007 Jul 30.
10
Multifocal and multicentric breast cancer: does each focus matter?多灶性和多中心性乳腺癌:每个病灶都重要吗?
J Clin Oncol. 2005 Oct 20;23(30):7497-502. doi: 10.1200/JCO.2005.02.1147.